company background image
M12 logo

M1 Kliniken XTRA:M12 Stock Report

Last Price

€14.14

Market Cap

€262.4m

7D

-6.1%

1Y

-20.8%

Updated

22 Jun, 2025

Data

Company Financials +

M1 Kliniken AG

XTRA:M12 Stock Report

Market Cap: €262.4m

M1 Kliniken (M12) Stock Overview

Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. More details

M12 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 72% below our estimate of its fair value

Earnings are forecast to grow 18.81% per year

Earnings grew by 55.9% over the past year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 87.4%

Risk Analysis

Unstable dividend track record


M12 Community Fair Values

Create Narrative

See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
40.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
38users have followed this narrative
16 days ago author updated this narrative

M1 Kliniken AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for M1 Kliniken
Historical stock prices
Current Share Price€14.14
52 Week High€19.00
52 Week Low€12.20
Beta0.85
1 Month Change-5.48%
3 Month Change-3.15%
1 Year Change-20.78%
3 Year Change170.88%
5 Year Change27.96%
Change since IPO182.86%

Recent News & Updates

Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business

Jun 13
Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business

M1 Kliniken's (ETR:M12) Dividend Will Be €0.50

May 24
M1 Kliniken's (ETR:M12) Dividend Will Be €0.50

Recent updates

Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business

Jun 13
Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business

M1 Kliniken's (ETR:M12) Dividend Will Be €0.50

May 24
M1 Kliniken's (ETR:M12) Dividend Will Be €0.50

Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?

Oct 15
Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?

Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%

Sep 24
Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%

Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge

Aug 03
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge

Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Jun 06
Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

May 29
M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

May 03
M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Mar 07
At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Feb 18
Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

Feb 17
Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Sep 01
An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

Jun 01
Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Mar 25
The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Dec 17
Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Nov 02
Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

May 26
Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

May 25
Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

Dec 06
Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

May 22
There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

Mar 19
Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

We're Watching These Trends At M1 Kliniken (ETR:M12)

Feb 21
We're Watching These Trends At M1 Kliniken (ETR:M12)

M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Feb 03
M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

Jan 16
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 29
M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 14
Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

When Should You Buy M1 Kliniken AG (ETR:M12)?

Nov 28
When Should You Buy M1 Kliniken AG (ETR:M12)?

Shareholder Returns

M12DE HealthcareDE Market
7D-6.1%-4.8%-1.2%
1Y-20.8%38.5%15.5%

Return vs Industry: M12 underperformed the German Healthcare industry which returned 38.5% over the past year.

Return vs Market: M12 underperformed the German Market which returned 15.5% over the past year.

Price Volatility

Is M12's price volatile compared to industry and market?
M12 volatility
M12 Average Weekly Movement7.3%
Healthcare Industry Average Movement6.2%
Market Average Movement5.9%
10% most volatile stocks in DE Market12.2%
10% least volatile stocks in DE Market3.1%

Stable Share Price: M12 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: M12's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007199Attila Strausswww.m1-kliniken.de

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.

M1 Kliniken AG Fundamentals Summary

How do M1 Kliniken's earnings and revenue compare to its market cap?
M12 fundamental statistics
Market cap€262.37m
Earnings (TTM)€16.02m
Revenue (TTM)€339.18m
16.4x
P/E Ratio
0.8x
P/S Ratio

Is M12 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M12 income statement (TTM)
Revenue€339.18m
Cost of Revenue€295.76m
Gross Profit€43.42m
Other Expenses€27.40m
Earnings€16.02m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.86
Gross Margin12.80%
Net Profit Margin4.72%
Debt/Equity Ratio8.0%

How did M12 perform over the long term?

See historical performance and comparison

Dividends

3.5%
Current Dividend Yield
59%
Payout Ratio

Does M12 pay a reliable dividends?

See M12 dividend history and benchmarks
When do you need to buy M12 by to receive an upcoming dividend?
M1 Kliniken dividend dates
Ex Dividend DateJul 17 2025
Dividend Pay DateJul 21 2025
Days until Ex dividend25 days
Days until Dividend pay date29 days

Does M12 pay a reliable dividends?

See M12 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/22 08:31
End of Day Share Price 2025/06/20 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

M1 Kliniken AG is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charlotte FriedrichsBerenberg
Stephan KleppCommerzbank AG
Edward AcklinFirst Berlin Equity Research GmbH